257 related articles for article (PubMed ID: 21768515)
21. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil.
Barco P; Cardoso RF; Hirata RD; Leite CQ; Pandolfi JR; Sato DN; Shikama ML; de Melo FF; Mamizuka EM; Campanerut PA; Hirata MH
J Antimicrob Chemother; 2006 Nov; 58(5):930-5. PubMed ID: 16971417
[TBL] [Abstract][Full Text] [Related]
22. Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China.
Pang Y; Zhu D; Zheng H; Shen J; Hu Y; Liu J; Zhao Y
BMC Infect Dis; 2017 Nov; 17(1):711. PubMed ID: 29110640
[TBL] [Abstract][Full Text] [Related]
23. Validation of pncA gene sequencing in combination with the mycobacterial growth indicator tube method to test susceptibility of Mycobacterium tuberculosis to pyrazinamide.
Simons SO; van Ingen J; van der Laan T; Mulder A; Dekhuijzen PN; Boeree MJ; van Soolingen D
J Clin Microbiol; 2012 Feb; 50(2):428-34. PubMed ID: 22090409
[TBL] [Abstract][Full Text] [Related]
24. Genotypic characterization of pyrazinamide resistance in Mycobacterium tuberculosis isolated from Lusaka, Zambia.
Bwalya P; Yamaguchi T; Mulundu G; Nakajima C; Mbulo G; Solo ES; Fukushima Y; Kasakwa K; Suzuki Y
Tuberculosis (Edinb); 2018 Mar; 109():117-122. PubMed ID: 29559115
[TBL] [Abstract][Full Text] [Related]
25. Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia.
Sengstake S; Bergval IL; Schuitema AR; de Beer JL; Phelan J; de Zwaan R; Clark TG; van Soolingen D; Anthony RM
BMC Infect Dis; 2017 Jul; 17(1):491. PubMed ID: 28697808
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of colorimetric methods using nicotinamide for rapid detection of pyrazinamide resistance in Mycobacterium tuberculosis.
Mirabal NC; Yzquierdo SL; Lemus D; Madruga M; Milián Y; Echemendía M; Takiff H; Martin A; Van der Stuyf P; Palomino JC; Montoro E
J Clin Microbiol; 2010 Aug; 48(8):2729-33. PubMed ID: 20554826
[TBL] [Abstract][Full Text] [Related]
27. Mycobacterium tuberculosis pncA Polymorphisms That Do Not Confer Pyrazinamide Resistance at a Breakpoint Concentration of 100 Micrograms per Milliliter in MGIT.
Whitfield MG; Warren RM; Streicher EM; Sampson SL; Sirgel FA; van Helden PD; Mercante A; Willby M; Hughes K; Birkness K; Morlock G; van Rie A; Posey JE
J Clin Microbiol; 2015 Nov; 53(11):3633-5. PubMed ID: 26292310
[TBL] [Abstract][Full Text] [Related]
28. Mycobacterium tuberculosis genotypic diversity in pyrazinamide-resistant isolates of Iran.
Doustdar F; Khosravi AD; Farnia P
Microb Drug Resist; 2009 Dec; 15(4):251-6. PubMed ID: 19857130
[TBL] [Abstract][Full Text] [Related]
29. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis in Brazil.
Rodrigues Vde F; Telles MA; Ribeiro MO; Cafrune PI; Rossetti ML; Zaha A
Antimicrob Agents Chemother; 2005 Jan; 49(1):444-6. PubMed ID: 15616332
[TBL] [Abstract][Full Text] [Related]
30. Pyrazinamide resistance associated with pncA gene mutation in Mycobacterium tuberculosis in Japan.
Endoh T; Yagihashi A; Uehara N; Kobayashi D; Tsuji N; Nakamura M; Hayashi S; Fujii N; Watanabe N
Epidemiol Infect; 2002 Apr; 128(2):337-42. PubMed ID: 12002553
[TBL] [Abstract][Full Text] [Related]
31. Rapid Pyrazinamide Drug Susceptibility Testing using a Closed-Tube PCR Assay of the Entire pncA gene.
Whitfield MG; Marras SAE; Warren RM; Van Rie A; Rice J; Wangh LJ; Kreiswirth BN
Sci Rep; 2020 Mar; 10(1):4234. PubMed ID: 32144379
[TBL] [Abstract][Full Text] [Related]
32. A new rapid and simple colorimetric method to detect pyrazinamide resistance in Mycobacterium tuberculosis using nicotinamide.
Martin A; Takiff H; Vandamme P; Swings J; Palomino JC; Portaels F
J Antimicrob Chemother; 2006 Aug; 58(2):327-31. PubMed ID: 16751203
[TBL] [Abstract][Full Text] [Related]
33. Discrepant results between pyrazinamide susceptibility testing by the reference BACTEC 460TB method and pncA DNA sequencing in patients infected with multidrug-resistant W-Beijing Mycobacterium tuberculosis strains.
Dormandy J; Somoskovi A; Kreiswirth BN; Driscoll JR; Ashkin D; Salfinger M
Chest; 2007 Feb; 131(2):497-501. PubMed ID: 17296653
[TBL] [Abstract][Full Text] [Related]
34. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from northwestern Russia.
Marttila HJ; Marjamäki M; Vyshnevskaya E; Vyshnevskiy BI; Otten TF; Vasilyef AV; Viljanen MK
Antimicrob Agents Chemother; 1999 Jul; 43(7):1764-6. PubMed ID: 10390239
[TBL] [Abstract][Full Text] [Related]
35. Pyrazinamide Susceptibility and
Rahman A; Ferdous SS; Ahmed S; Rahman SMM; Uddin MKM; Pholwat S; Gratz J; Houpt E; Banu S
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630193
[TBL] [Abstract][Full Text] [Related]
36. Characterization of pncA gene mutations in pyrazinamide-resistant Mycobacterium tuberculosis isolates from Mexico.
Cuevas-Córdoba B; Xochihua-González SO; Cuellar A; Fuentes-Domínguez J; Zenteno-Cuevas R
Infect Genet Evol; 2013 Oct; 19():330-4. PubMed ID: 23321280
[TBL] [Abstract][Full Text] [Related]
37. pncA mutations as a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis: spread of a monoresistant strain in Quebec, Canada.
Cheng SJ; Thibert L; Sanchez T; Heifets L; Zhang Y
Antimicrob Agents Chemother; 2000 Mar; 44(3):528-32. PubMed ID: 10681313
[TBL] [Abstract][Full Text] [Related]
38. Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance.
Zimic M; Fuentes P; Gilman RH; Gutiérrez AH; Kirwan D; Sheen P
Tuberculosis (Edinb); 2012 Jan; 92(1):84-91. PubMed ID: 22004792
[TBL] [Abstract][Full Text] [Related]
39. Gene sequencing for routine verification of pyrazinamide resistance in Mycobacterium tuberculosis: a role for pncA but not rpsA.
Alexander DC; Ma JH; Guthrie JL; Blair J; Chedore P; Jamieson FB
J Clin Microbiol; 2012 Nov; 50(11):3726-8. PubMed ID: 22895038
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment.
Driesen M; Kondo Y; de Jong BC; Torrea G; Asnong S; Desmaretz C; Mostofa KSM; Tahseen S; Whitfield MG; Cirillo DM; Miotto P; Cabibbe AM; Rigouts L
Clin Microbiol Infect; 2018 Jan; 24(1):60-64. PubMed ID: 28587904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
